• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌放化疗期间细胞因子水平、急性黏膜炎严重程度和 PEG 管安装需求的前瞻性初步研究。

Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer--a prospective pilot study.

机构信息

Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

出版信息

Radiat Oncol. 2010 Feb 25;5:16. doi: 10.1186/1748-717X-5-16.

DOI:10.1186/1748-717X-5-16
PMID:20184737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2837669/
Abstract

BACKGROUND

The purpose of this pilot study was to detect a correlation between serum cytokine levels and severity of mucositis, necessitating installation of a percutaneous endoscopic gastrostomy tube (PEG) in head and neck (H&N) cancer patients receiving combined chemo-radiation therapy.

PATIENTS AND METHODS

Fifteen patients with H&N epithelial cancer were recruited to this study. All patients received radiotherapy to the H&N region, with doses ranging from 50-70 Gy. Chemotherapy with cisplatin, carboplatin, 5-fluorouracil and taxanes was given to high-risk patients, using standard chemotherapy protocols. Patients were evaluated for mucositis according to WHO common toxicity criteria, and blood samples were drawn for inflammatory (IL-1, IL-6, IL-8, TNF-alpha) and anti-inflammatory (IL-10) cytokine levels before and during treatment.

RESULTS

A positive correlation was found between IL-6 serum levels and severity of mucositis and dysphagia; specifically, high IL-6 levels at week 2 were correlated with a need for PEG tube installation. A seemingly contradictory correlation was found between low IL-8 serum levels and a need for a PEG tube.

CONCLUSION

These preliminary results, indicating a correlation between IL-6 and IL-8 serum levels and severity of mucositis and a need for a PEG tube installation, justify a large scale study.

摘要

背景

本初步研究旨在检测头颈癌(H&N)患者接受放化疗联合治疗时血清细胞因子水平与黏膜炎严重程度和需行经皮内镜下胃造口术(PEG)之间的相关性。

患者与方法

本研究共纳入 15 例 H&N 上皮癌患者。所有患者均接受 H&N 区域放疗,剂量为 50-70Gy。高危患者接受顺铂、卡铂、氟尿嘧啶和紫杉烷类药物的化疗,采用标准化疗方案。根据世界卫生组织(WHO)通用毒性标准对患者进行黏膜炎评估,并在治疗前后采集血液样本检测炎症(IL-1、IL-6、IL-8、TNF-α)和抗炎(IL-10)细胞因子水平。

结果

IL-6 血清水平与黏膜炎和吞咽困难的严重程度呈正相关;具体而言,第 2 周时高 IL-6 水平与需要行 PEG 管安装相关。IL-8 血清水平与需要行 PEG 管之间存在似乎矛盾的相关性。

结论

这些初步结果表明,IL-6 和 IL-8 血清水平与黏膜炎严重程度和需要行 PEG 管安装之间存在相关性,支持开展更大规模的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a2/2837669/ff1785be0270/1748-717X-5-16-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a2/2837669/99c9f151e087/1748-717X-5-16-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a2/2837669/ff1785be0270/1748-717X-5-16-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a2/2837669/99c9f151e087/1748-717X-5-16-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a2/2837669/ff1785be0270/1748-717X-5-16-2.jpg

相似文献

1
Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer--a prospective pilot study.头颈部癌放化疗期间细胞因子水平、急性黏膜炎严重程度和 PEG 管安装需求的前瞻性初步研究。
Radiat Oncol. 2010 Feb 25;5:16. doi: 10.1186/1748-717X-5-16.
2
Survey of pre-inflammation cytokines levels in radiotherapy-induced-mucositis.放疗诱导性口腔黏膜炎中炎症前细胞因子水平的调查
Pak J Biol Sci. 2012 Nov 15;15(22):1098-101. doi: 10.3923/pjbs.2012.1098.1101.
3
Effect of irradiation on cytokine production in cancer patients.辐射对癌症患者细胞因子产生的影响。
Int J Biol Markers. 2022 Dec;37(4):360-367. doi: 10.1177/03936155221116388. Epub 2022 Aug 4.
4
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.局部晚期头颈癌患者每周使用卡铂/紫杉醇同步放化疗联合或不联合每日皮下注射氨磷汀的随机2期研究。
Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525.
5
Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.头颈部癌症中接受西妥昔单抗联合放疗的患者具有独特的黏膜炎和进食管依赖。
Jpn J Clin Oncol. 2015 Feb;45(2):183-8. doi: 10.1093/jjco/hyu196. Epub 2014 Nov 23.
6
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.头颈部癌症患者化疗和放疗后唾液细胞因子水平与口腔黏膜炎。
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):959-966. doi: 10.1016/j.ijrobp.2016.08.047. Epub 2016 Sep 6.
7
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.帕利夫明与同步放化疗联合治疗头颈部鳞状细胞癌的II期研究。
J Clin Oncol. 2008 May 20;26(15):2489-96. doi: 10.1200/JCO.2007.13.7349.
8
Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer.早期经皮内镜下胃造口术置管可维持上消化道癌症患者的营养状况。
Nutr Cancer. 2005;52(1):29-34. doi: 10.1207/s15327914nc5201_4.
9
Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?头颈部癌治疗期间的肠内营养:经皮内镜下胃造口管是否比鼻胃管更具优势?
Cancer. 2001 May 1;91(9):1785-90.
10
Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.头颈部癌症放化疗期间的肠内营养支持:采用反应式方法的单机构经验。
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):763-9. doi: 10.1016/j.ijrobp.2009.12.032. Epub 2010 May 24.

引用本文的文献

1
Predictors of Gastrostomy Tube Placement in Head and Neck Cancer Patients Undergoing Radiation or Chemoradiotherapy: A Systematic Review.接受放疗或放化疗的头颈癌患者胃造口管置入的预测因素:一项系统评价
Head Neck. 2025 Mar;47(3):1006-1017. doi: 10.1002/hed.28010. Epub 2024 Nov 25.
2
Oral mucositis management with photobiomodulation, Bidens pilosa L. (Asteraceae) and Curcuma longa L. (Zingiberaceae), the FITOPROT herbal medicine, and its influence on inflammatory cytokine levels: a randomized clinical trial.光生物调节、三叶鬼针草(菊科)和姜黄(姜科)联合植物药 FITOPROT 治疗口腔黏膜炎及其对炎症细胞因子水平的影响:一项随机临床试验。
Support Care Cancer. 2024 Sep 2;32(9):628. doi: 10.1007/s00520-024-08842-3.
3

本文引用的文献

1
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.局部晚期头颈癌患者每周使用卡铂/紫杉醇同步放化疗联合或不联合每日皮下注射氨磷汀的随机2期研究。
Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525.
2
Interleukin-6 predicts recurrence and survival among head and neck cancer patients.白细胞介素-6可预测头颈癌患者的复发和生存情况。
Cancer. 2008 Aug 15;113(4):750-7. doi: 10.1002/cncr.23615.
3
Systematic review of the association between circulating interleukin-6 (IL-6) and cancer.
Effect of Photobiomodulation on Salivary Cytokines in Head and Neck Cancer Patients with Oral Mucositis: A Systematic Review.
光生物调节对患有口腔黏膜炎的头颈癌患者唾液细胞因子的影响:一项系统评价。
J Clin Med. 2024 May 10;13(10):2822. doi: 10.3390/jcm13102822.
4
Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitis.单细胞转录组学揭示了衰老相关的 IL-6/CCR6 轴驱动放射性皮炎。
EMBO Mol Med. 2022 Aug 8;14(8):e15653. doi: 10.15252/emmm.202115653. Epub 2022 Jul 4.
5
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial.白细胞介素-6 作为头颈部癌症患者接受根治性放化疗时基于影像学的缺氧动态的替代标志物-前瞻性试点研究的结果。
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1650-1660. doi: 10.1007/s00259-021-05602-x. Epub 2021 Nov 13.
6
Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice.纳米包封阿霉素可预防小鼠口腔黏膜炎的发生。
Pharmaceutics. 2021 Jul 4;13(7):1021. doi: 10.3390/pharmaceutics13071021.
7
The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy.接受手术及盆腔放化疗的妇科癌症患者腹泻与血清细胞因子之间的关联。
Clin Transl Radiat Oncol. 2021 Jun 9;29:60-64. doi: 10.1016/j.ctro.2021.05.010. eCollection 2021 Jul.
8
A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma.一项使用改良益生菌预防鼻咽癌同期放化疗所致口腔黏膜炎的 II 期随机临床试验及机制研究。
Front Immunol. 2021 Mar 24;12:618150. doi: 10.3389/fimmu.2021.618150. eCollection 2021.
9
Oral mucositis: the hidden side of cancer therapy.口腔黏膜炎:癌症治疗的隐匿面。
J Exp Clin Cancer Res. 2020 Oct 7;39(1):210. doi: 10.1186/s13046-020-01715-7.
10
Oil Mouth Rinse Improves Chemotherapy-Induced Oral Mucositis in Patients with Acute Myeloid Leukemia.含油漱口液可改善急性髓系白血病患者化疗引起的口腔黏膜炎。
Biomed Res Int. 2019 Oct 30;2019:3619357. doi: 10.1155/2019/3619357. eCollection 2019.
循环白细胞介素-6(IL-6)与癌症关联的系统评价
Eur J Cancer. 2008 May;44(7):937-45. doi: 10.1016/j.ejca.2008.02.047. Epub 2008 Apr 1.
4
Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma.白细胞介素-1β、-4、-6、-8、-10以及肿瘤坏死因子-α、-β的基因表达多态性:其对口腔鳞状细胞癌影响的回归分析
J Cancer Res Clin Oncol. 2008 Aug;134(8):821-32. doi: 10.1007/s00432-008-0360-z. Epub 2008 Feb 14.
5
Apoptotic and inflammation markers in oral mucositis in head and neck cancer patients receiving radiotherapy: preliminary report.接受放疗的头颈癌患者口腔黏膜炎中的凋亡和炎症标志物:初步报告。
Support Care Cancer. 2008 Sep;16(9):1025-33. doi: 10.1007/s00520-007-0379-8. Epub 2008 Jan 16.
6
Interleukin-6 directly influences proliferation and invasion potential of head and neck cancer cells.
Eur Arch Otorhinolaryngol. 2007 Jul;264(7):815-21. doi: 10.1007/s00405-007-0264-6. Epub 2007 Feb 20.
7
Mucositis pain induced by radiation therapy: prevalence, severity, and use of self-care behaviors.放射治疗引起的黏膜炎疼痛:患病率、严重程度及自我护理行为的应用
J Pain Symptom Manage. 2006 Jul;32(1):27-37. doi: 10.1016/j.jpainsymman.2005.12.020.
8
Oral complications of radiotherapy.放射治疗的口腔并发症
Lancet Oncol. 2006 Feb;7(2):175-83. doi: 10.1016/S1470-2045(06)70580-0.
9
The role of IL-6 and STAT3 in inflammation and cancer.白细胞介素-6和信号转导及转录激活因子3在炎症和癌症中的作用。
Eur J Cancer. 2005 Nov;41(16):2502-12. doi: 10.1016/j.ejca.2005.08.016. Epub 2005 Sep 30.
10
Audit of nutritional guidelines for head and neck cancer patients undergoing radiotherapy.对头颈部癌症放疗患者营养指南的审核。
J Hum Nutr Diet. 2005 Oct;18(5):343-51. doi: 10.1111/j.1365-277X.2005.00632.x.